Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. Update on CARB-XED and DRIVE AB Final Conference

   John H. Rex, Wellesley, United States

   06 September 2017

   Relevance:

    

   100%

    

   

   Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
   Boston, United States
   Conference lecture

   Bacterial Susceptibility & Resistance

2. Drug Penetration and the Multiple Target Hypothesis: Two Challenges to Antibacterial Discovery

   Lynn Silver, Springfield, United States

   06 September 2017

   Relevance:

    

   100%

    

   

   Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
   Boston, United States
   Conference lecture

   Bacterial Susceptibility & Resistance

3. Old Drug/New Formulation for Europe: Minocycline

   Jeffery Loutit, San Diego, United States

   06 September 2017

   Relevance:

    

   83%

    

   

   Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
   Boston, United States
   Conference lecture

   Bacterial Susceptibility & Resistance

4. Relationship Between Gepotidacin (GSK1440944) Pharmacokinetics-Pharmacodynamics and Escherichia coli Resistance Amplification Prevention in a Hollow-Fiber Infection Model (HFIM)

   Brian VanScoy, Latham, United States

   06 September 2017

   Relevance:

    

   70%

    

   

   Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
   Boston, United States
   Conference lecture

   Bacterial Susceptibility & Resistance

5. FDA Updates and Perspectives

   Sumathi Nambiar, Silver Spring, United States

   06 September 2017

   Relevance:

    

   69%

    

   

   Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
   Boston, United States
   Conference lecture

   Bacterial Susceptibility & Resistance

6. Critically Ill Patients versus Healthy Volunteers

   Jason Roberts, Brisbane, Australia

   06 September 2017

   Relevance:

    

   69%

    

   

   Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
   Boston, United States
   Conference lecture

   Bacterial Susceptibility & Resistance

7. Targeting a Single Species: Acinetobacter baumannii

   Robin Isaacs, Whitehouse Station, United States

   06 September 2017

   Relevance:

    

   69%

    

   

   Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
   Boston, United States
   Conference lecture

   Bacterial Susceptibility & Resistance

8. Strategic Priority for AMR

   Tim Jinks, Cambridge, United Kingdom

   06 September 2017

   Relevance:

    

   69%

    

   

   Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
   Boston, United States
   Conference lecture

   Bacterial Susceptibility & Resistance

9. Neonates and Infants

   Mike Sharland, London, United Kingdom

   06 September 2017

   Relevance:

    

   69%

    

   

   Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
   Boston, United States
   Conference lecture

   Bacterial Susceptibility & Resistance

10. Outer Membrane Permeabilizer

    Aileen Rubio, Cambridge, United States

    06 September 2017

    Relevance:

     

    69%

     

    

    Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Boston, United States
    Conference lecture

    Bacterial Susceptibility & Resistance